Boston Scientific appointed Joseph M. Fitzgerald as COO effective Jan. 1, 2027, and will reorganize into three reportable segments: Interventional Therapies, Rhythm Solutions and MedSurg.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
